Foundry Partners’s BioTelemetry, Inc. BEAT Stock Holding History

Foundry Partners’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-18,281	Closed	-$1.32M	–	459
2020 Q4	$1.32M	Sell	18,281 -10,556	-37%	-$553K	0.05%	317
2020 Q3	$1.31M	Sell	28,837 -340	-1%	-$14.2K	0.06%	294
2020 Q2	$1.32M	Sell	29,177 -1,119	-4%	-$50.1K	0.06%	287
2020 Q1	$1.17M	Buy	+30,296	New	+$1.39M	0.07%	284

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Foundry Partners's BEAT Position: Q1 2021 in Review

Foundry Partners sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 18,281 shares — an estimated $1.32M sold.

Foundry Partners first reported a position in BEAT in Q1 2020 and held it in 4 quarters. The position peaked at $1.32M in Q2 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Foundry Partners reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Foundry Partners sold 18,281 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.32M.
Foundry Partners first reported a position in BioTelemetry, Inc. in Q1 2020 and held it in 4 quarters.
Foundry Partners's BioTelemetry, Inc. position peaked at $1.32M in Q2 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Foundry Partners's 13F filing for Q1 2021, filed 12 May 2021.